Morgan Stanley Reiterates Buy on Globe Life (GL) Shares

Group 1 - Morgan Stanley has reiterated a Buy rating on Globe Life Inc. (NYSE:GL) with a price target of $176 as of February 23, 2026 [1] - Globe Life Inc. reported a net income increase to $266 million, or $3.29 per share, for the fourth quarter and full year 2025, up from $255 million, or $3.01 per share, in 2024 [3] - The company experienced an $8 million decrease in excess investment income due to lower average invested asset growth and lower average earned yield [3] Group 2 - Michael Clay Majors, Executive Vice President and Chief Strategy Officer of Globe Life, sold 30,000 shares valued at approximately $4.41 million, reducing his ownership stake by 39% [2] - Globe Life Inc. provides life and supplemental health insurance for middle-income families and was founded in 1900 [4] - The company's 2026 earnings guidance includes a net operating income range of $14.95 to $15.65 per share [3]